Sfoglia per AUTORE
ROSS DM
Collezione AOU Alessandria
Items : 2
Phase 2 study of the lysine-specific demethylase 1 inhibitor bomedemstat for essential thrombocythemia. in Blood advances / Blood Adv. 2026 May 26;10(10):3494-3504. doi: 10.1182/bloodadvances.2025017575.
2026
AOU Alessandria
AOU Alessandria
Gill H; Palandri F; Ross DM; Göthert JR; Cochrane T; Larsen SR; Halpern AB; Shortt J; Rossetti JM; Liang J; Marchetti M; Wilson AJ; Innes AJ; Hanna M; Vianelli N; Stevenson WS; Vannucchi AM; Kleppe M; Flynn J; Natsoulis G; Harrison CN; Rienhoff HY Jr;
The lysine-specific demethylase 1 (LSD1) inhibitor bomedemstat in myelofibrosis: results from a phase 1/2 study. in Blood advances / Blood Adv. 2026 Jul 14;10(13):4585-4594. doi: 10.1182/bloodadvances.2025018141.
2026
AOU Alessandria
AOU Alessandria
Gill H; Yacoub A; Gerds AT; Shortt J; Rossetti JM; Mead AJ; Göthert JR; Koschmieder S; Ewing J; Halpern AB; Palandri F; Passamonti F; Mesa R; Marchetti M; Harrison C; Vannucchi AM; Watts JM; Wood JC; Ross DM; Peppe J; Natsoulis G; Rienhoff HY Jr;